Dahl; Edgar
Patent Applications and Registrations
Patent applications and USPTO patent grants for Dahl; Edgar.The latest application filed is for "biomarker for breast cancer".
- Dahl; Edgar - Kelmis BE
- Dahl, Edgar - Potsdam DE
| Patent | Date |
|---|---|
| Compounds for the treatment of cancer Grant 10,457,718 - Dahl , et al. Oc | 2019-10-29 |
| Biomarker For Breast Cancer App 20190017124 - DAHL; Edgar ; et al. | 2019-01-17 |
| Novel Compounds For The Treatment Of Cancer App 20170362303 - Dahl; Edgar ; et al. | 2017-12-21 |
| Biomarker For Bladder Cancer App 20160083797 - Rose; Michael ; et al. | 2016-03-24 |
| Human nucleic acid sequences from prostate tumor tissue App 20040009478 - Specht, Thomas ; et al. | 2004-01-15 |
| Human nucleic acid sequences which are overexpressed in normal pancreas tissue App 20040002471 - Specht, Thomas ; et al. | 2004-01-01 |
| Human-nucleic acid sequences from breast tumor tissue App 20030235915 - Specht, Thomas ; et al. | 2003-12-25 |
| Human nucleic acid sequences from endometrial tumor tissue Grant 6,620,923 - Specht , et al. September 16, 2 | 2003-09-16 |
| Human nucleic acid sequences from ovarian tumor tissue App 20030105315 - Specht, Thomas ; et al. | 2003-06-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 